New cancer drug fights tumours in those with BRCA mutations
Wednesday, 1 July 2009- A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies.
Women who carry BRCA1 and BRCA2 gene mutations are susceptible to developing breast and ovarian...
Live donor kidney tranplantation - also for older patients
Tuesday, 30 June 2009- Almost half of kidney transplant candidates older than 60 who are put on the waiting list for a deceased-donor organ will die before getting a transplant, according to new findings from the University of Florida, Cleveland Clinic and Case Western Reserve University.Wait times to receive a...










